Taking Stock
Rx Savings' Rea on Mylan Under Scrutiny for EpiPen Price(Audio)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:08:45
- More information
Informações:
Synopsis
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Michael Rea, CEO of Rx Savings Solutions, to discuss Mylan's EpiPen price hike, currently under scrutiny.
